Xiaowei Dong

Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP.

Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.

p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer.

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Precise method for modifying birefringence of stress-induced high-birefringence fiber.

Prevalence and related factors of irritable bowel syndrome among middle-school students in areas affected by Wenchuan Earthquake: an epidemiological study.

Solubilization of tea seed oil in a food-grade water-dilutable microemulsion.

Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.

Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.

Impaired Dendritic Development and Memory in Sorbs2 Knock-Out Mice.

Novel in situ self-assembly nanoparticles for formulating a poorly water-soluble drug in oral solid granules, improving stability, palatability, and bioavailability.

Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.